Methylenedioxymethamphetamine-induced serotonin deficits Are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 846-854

  Sabol, Karen E ^a   Lew, Robert ^a   Richards, Jerry B ^a   Vosmer, Georgetta L ^a   Seiden, Lewis S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; SEROTONIN; SEROTONIN RECEPTOR AFFECTING AGENT;

ANIMAL; ARTICLE; BRAIN LEVEL; DRUG EFFECT; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; SYNAPTOSOME; TIME;

ANIMALS; BRAIN CHEMISTRY; DOPAMINE; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; SYNAPTOSOMES; TIME FACTORS;

EID: 0030087890     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. AXT, K. J., MAMOUNAS, L A. AND MOLLIVER, M. E.: Regeneration of 5-HT projections to neocortex: magnitude of p-chloroamphetamine-induced denervation influences reinnervation. Soc. Neurosci. Abs. 18: 629, 1992.
2. AZMITIA, E. C. AND SEGAL, M.: An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179: 641-668, 1978.
3. BATTAGLIA, G., SHARKEY, J., KUHAR, M. J. AND DESOUZA, E. B.: Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (2,3-methylenedioxymethamphetamine): Assessment using quantitative autoradiography. Synapse 8: 249-260, 1991.
4. BATTAGLIA, G., YEH, S. Y. AND DESOUZA, E. B.: MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons. Pharmacol. Biochem. Behav. 29: 269-274, 1988.
5. BATTAGLIA, G., YEH, S. Y., O'HEARN, E., MOLLIVER, M. E., KUHAR, M. J. AND DESOUZA, E. B.: 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J. Pharmacol. Exp. Ther. 242: 911-916, 1987.
6. BJORKLUND, A., NOBIN, A. AND STENEVI, U.: Regeneration of central serotonin neurons after axonal degeneration induced by 5,6-dahydroxytryptamine. Brain Res. 50: 214-220, 1973.
7. BOWYER, J. F., TANK, A. W., NEWPORT, G. D., SLIKKER, W., ALI, S. F. AND HOLSON, R. R.: The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striaturn. J. Pharmacol. Exp. Ther. 260: 817-824, 1992.
8. COMMINS, D. L., VOSMER, G., VIRUS, R. M., WOOLVERTON, W. L., SCHUSTER, C. R. AND SEIDEN, L. S.: Biochemical and histological evidence that methylenedioxymethlyamphetamine (MDMA) is toxic to neurons in the rat brain. J. Pharmacol. Exp. Ther. 241: 338-345, 1987.
9. DESOUZA, E. B., BATTAGLIA, G. AND INSEL, T. R.: Neurotoxic effects of MDMA on brain serotonin neurons: evidence from neurochemical radioligand binding studies. Ann. N.Y. Acad. Sci. 600: 682-698, 1990.
10. HEFFNER, T. G., HARTMAN, J. A. AND SEIDEN, L. S.: A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem Behav. 13: 453-456, 1980.
11. HOLZ, R. W. AND COYLE, J. T.: The effects of various salts, temperature, and the alkaloids veratridine and batrachotoxin on the uptake of [3H] dopamine into synaptosomes from rat striatum. Mol. Pharmacol. 10: 746-748, 1974.
12. KLEVEN, M. S., WOOLVERTON, W. L. AND SEIDEN, L. S.: Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Brain Res. 488: 121-125, 1989.
13. LEW, R., SABOL, K. E., CHOU, C., VOSMER, G. L., RICHARDS, J. B., AND SEIDEN, L. S.: Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies. J. Pharmacol. Exp. Ther. 276: 855-865, 1996.
14. LIDOV, H. G. W., GRZANNA, R. AND MOLLIVER, M. E.: The serotonin innervation of the cerebral cortex in the rat - an immunohistochemical analysis. Neuroscience 5: 207-227, 1980.
15. MOORE, R. Y., HALARIS, A. E. AND JONES, B. E.: Serotonin neurons of the midbrain raphe: Ascending projections J. Comp. Neurol. 180: 417-438, 1978.
16. O'HEARN, E., BATTAGLIA, G., DESOUZA, E. B., KUHAR, M. J. AND MOLLIVER, M E.: Methylenedioxyamphetamine (MDA) and methylenedioxyniethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 8: 2788-2803, 1988.
17. O'REILLY, C. A. AND REITH, M. A.: Uptake of [3H]Serotonin into plasma membrane vesicles from mouse cerebral cortex. J. Biol. Chem 263: 6115-6121, 1988.
18. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, 2nd ed. Orlando, FL: Academic Press Inc., 1986.
19. REITH, E. A. AND O'REILLY, C. A.: Inhibition of serotonin uptake into mouse brain synaptosomes by ionophores and ion-channel agents. Br Res. 521: 347-351, 1990.
20. RICAURTE, G. A., MARTELLO, A. L., KATZ, J. L. AND MARTELLO, M. B.: Lasting effects of (±)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: Neurochemical observations. J. Pharmacol. Exp. Ther. 261: 616-622, 1992.
21. RICHARDS, J. B., BAGGOTT, M. J., SABOL, K. E. AND SEIDEN, L. S.: A high-dose methamphetamine regimen results in long lasting deficits on the performance of a reaction time task. Brain Res. 627: 254-260, 1993.
22. SCANZELLO, C. R., HATZIDIMITRIOU, G., MARTELLO, A. L., KATZ, J. L. AND RICAURTE, G. A.: Response of central serotonergic neurons to (±)3,4-methylenedioxymethamphetamine (MDMA) injury: Observations in rats. J. Pharmacol. Exp. Ther. 264: 1484-1491, 1993.
23. SCHMIDT, C. J.: Neurotoxieity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240: 1-7, 1987.
24. SCHMIDT, C. J., BLACK, C. K., ABBATE, G. M. AND TAYLOR, V. L.: Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors. Brain Res. 529: 85-90, 1990.
25. SCHMIDT, C. J., WU, L. AND LOVENBERG, W.: Methylenedioxymethamphetamine: A potentially neurotoxic amphetamine analogue. Eur. J. Pharmacol. 124: 175-178, 1986.
26. SEIDEN, L. S. AND SABOL, K. E.: Neurotoxicity of Methamphetamine-Related Drugs and Cocaine. Marcel Dekker, Inc., New York, 1995.
27. TOHYAMA, M., SHIOSAKA, S., SAKANAKA, M., TAKAGI, H., SENBA, E., SAITOH, Y., TAKAHASHI, Y., SAKUMOTO, T. AND SHIMIZU, N.: Detailed pathways of the raphe dorsalis neuron to the cerebral cortex with use of horseradish peroxidase3,3′, 5,5′tetramethyl benzidine reaction as a tool for the fiber tracing technique. Brain Res. 181: 433-439, (1980).
28. TORK, I.: Raphe nuclei and serotonin containing systems. In The Rat Nervous System, ed. by G. Paxinos, pp. 43-78, Academic Press, New York, 1985.
29. ZIGMOND, M. J., STACHOWIAK, M. K., BERGER, T. W. AND STRICKER, E. M.: Neurochemical events underlying continued function despite injury to monoaminergic systems. Exp. Brain Res. (suppl. 13): 120-128, 1986.